The National Institute of Neurological Disorders and Stroke (NINDS) encourages grant applications for research on genetic and genomic analyses of Xenopus. This announcement is made together with 9 other components of the National Institutes of Health (NIH).*
The purpose of this announcement is to encourage researchers to use the newly generated methodologies and reagents, such as the clones and sequence information, to identify and characterize genes, gene families, and gene networks that control developmental and cellular events, and to generate research tools and perform pilot studies. Additionally, this announcement invites scientists to devise and improve techniques to alter gene expression, and to control the spatial and temporal pattern of gene expression.
Examples of research projects include, but are not limited to: development and/or application of novel methods of mutagenesism and novel screens for mutants; development and/or use of techniques supporting more efficient targeting of induced local lesions in genomes (TILLING); development and/or use of technologies for gene inactivation and gene expression manipulation; and development of high-throughput small molecule screens, new genetic or genomic resources that are of high priority for the Xenopus community, and screens focusing on identifying novel developmental genes and pathways.
LETTERS OF INTENT RECEIPT DATE:
APPLICATION RECEIPT DATE:
For more information, potential applicants should contact Dr. Steven Klein, Developmental Biology, Genetics and Teratology Branch, National Institute of Child Health and Human Development (NICHD), Room 4B01, 6100 Executive Boulevard, Bethesda, MD 20892; telephone: 301-435-6886; e-mail: email@example.com.
*For a full list of supporting NIH components and a more detailed description of this announcement, please visit the NIH web site at: http://grants.nih.gov/grants/guide/pa-files/PAR-05-166.html.